Results 91 to 100 of about 2,816 (159)

Latent Tuberculosis Infection among Household Contacts of Tuberculosis Patients, Healthcare Workers, and Tuberculosis Patients Using QuantiFERON-tuberculosis Gold Plus and Tuberculin Skin Test in a Tertiary Care Hospital Setting Bhubaneswar, Odisha – A Cross-sectional Study

Journal of Global Infectious Diseases
Introduction: Contacts of tuberculosis (TB) patients have an increased risk of latent TB infection (LTBI). Currently, it is diagnosed using one of the two methods: Tuberculin skin test (TST) or QuantiFERON-TB Gold Plus.
Braja Sundar Barik, Chinmay Divyadarshi Kar, Shritam Das, Tahziba Hussain, Sasmita Nayak, Arun Kumar Sahu, Sooman Sundaray, Sanghamitra Pati   +7 more
doaj   +1 more source

Serial Assays of QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold-Plus in Subjects Exposed to Patients with Active Tuberculosis

Annals of Laboratory Medicine, 2020
Hee-Won Moon, Ahram Yi, Sumi Yoon, Hanah Kim, Hee-Jung Chung, Mina Hur, Yeo-Min Yun, Kwang Ha Yoo   +7 more
openaire   +3 more sources

UEG Week 2025 Poster Presentations

United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Aktif tüberküloz hastalarında tedavi öncesi ve tedavi sonrası Quantiferon-TB Gold Plus testi sonuçlarının değerlendirilmesi

, 2023
Tıp Fakültesi, Tıbbi Mikrobiyoloji A.B.D. Araştırma ProjesiAraştırma Projesi elektronik ortamda bulunmaktadır.AMAÇ: Latent tüberküloz enfeksiyonu (LTBE)'nun tespiti için önemli tanı testlerinden birisi interferon-? (IFN) salım testleri(IGST)dir.
Çavuşoğlu, Cengiz
core  

Experiences from Ukraine in expanding TB infection diagnosis and treatment, including for drug-resistant TB

IJTLD Open
BACKGROUND: Ukraine faces intersecting epidemics of HIV and drug-resistant TB (DR-TB), with high risk of progression from TB infection to active disease.
V. Shukatka, L. Skoklyuk, M. Germanovych, A. Bogdanov, T. Ivanenko, N. Zherebko, E. Klinkenberg, G. Dravniece   +7 more
doaj   +1 more source

First characterization of the CD4 and CD8 T-cell responses to QuantiFERON-TB Plus

, 2016
SummaryIntroductionQuantiFERON®-TB Gold Plus (QFT-Plus) is the new generation of QuantiFERON-TB Gold In-Tube test to identify latent tuberculosis infection (LTBI). QFT-Plus includes TB1 and TB2 tubes which contain selected Mycobacterium tuberculosis (Mtb)
Barcellini, Lucia, Palmieri, Fabrizio, Ippolito, Giuseppe, Vanini, Valentina, Cirillo, Daniela Maria, Pepponi, Ilaria, Petruccioli, Elisa, Goletti, Delia, Urso, Rocco, Chiacchio, Teresa, Cuzzi, Gilda   +10 more
core   +1 more source

Evaluation of a Fluorescence Immunoassay-Based IGRA for Latent Tuberculosis Diagnosis: A Simplified, Cost-Effective Alternative

Microorganisms
Approximately 25% of the global population is estimated to have latent tuberculosis infection (LTBI), with a 5–10% lifetime risk of progression to active disease.
Mohammad Khaja Mafij Uddin, Aar Rafi Mahmud, Afsana Akter Rupa, Ashabul Islam, Jahin Fairuj Oishi, Jannatul Ferdous, Rumana Nasrin, Syed Mohammad Mazidur Rahman, Senjuti Kabir, Shahriar Ahmed, Sayera Banu   +10 more
doaj   +1 more source

Evaluation of QIAreach QuantiFERON-TB lateral-flow nanoparticle fluorescence assay for TB infection diagnosis among TB household contacts in three high-burden settings.

PLoS ONE
BackgroundTuberculosis infection (TBI) testing, and treatment are fundamental to achieve TB elimination. TBI testing among close or household contacts (HHCs) has been limited, in part due to perceived complexity and high operational cost.
Thobani Ntshiqa, Akinlolu Fasanmi, Jeniffer Nagudi, Lindiwe Tsope, Andrew Copas, Stacie Stender, Issa Sabi, Elias Nyanda Ntinginya, Julieth Lalashowi, Manthomeng Matete, Lula Budiaki, Malebo Mahlalela, Abisai Kisinda, Don Mudzengi, Lilian Tina Minja, Tobias Chirwa, Knut Lönnroth, Stefan Niemann, Viola Dreyer, Salome Charalambous, Kavindhran Velen, Yohhei Hamada, Molebogeng Rangaka   +22 more
doaj   +1 more source

Evaluation of three novel antigens and costimulatory agents for improvement of M. Tuberculosis specific interferon gamma release assays

BMC Infectious Diseases
Background Mycobacterium tuberculosis (MT) infections represent a global health problem and latent tuberculosis infection (LTBI) affects an estimated 25% of the world population. 10.6 million people fell ill with tuberculosis (TB) worldwide in 2021 and a
Sandra Schwarzlose-Schwarck, Mark Reinwald, Torsten Bauer, Florian Hentschel, Til Kiderlen, Dorinja Zapf, Victor Herbst, Stefan Lüth, David Krieger, Werner Dammermann   +9 more
doaj   +1 more source